Hexamethylene bisacetamide (HMBA) is a small-molecule research chemical used as a cell differentiation inducer and selective bromodomain inhibitor. It induces tumor cell differentiation, inhibits cell proliferation, and has been reported to modulate signaling pathways including Notch1, Bcl-2, and p53. The compound is supplied in solid and solution formats for laboratory studies in cell biology, pharmacology, and cancer research.
- Induces cell differentiation in vitro.
- Modulates Notch1, Bcl-2, and p53 signaling pathways.
- Reported antitumor and antiproliferative activity.
- Available as solid powder and DMSO solution formats.
- Suitable for cell biology and pharmacology research.